Puma Biotech (PBYI) Announces EMA Validation of Neratinib MAA
Go back to Puma Biotech (PBYI) Announces EMA Validation of Neratinib MAAPUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) | Delayed: 5.13 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $5.13 | 52 Week High | $82.81 | |||
Open | $5.13 | 52 Week Low | $19.74 | |||
Day High | $5.13 | P/E | N/A | |||
Day Low | $5.13 | EPS | $-2.16 | |||
Volume | 2,848 |